Similarly, another study utilized a kidney organoid-on-chip model to test the off-target effects of a bispecific antibody targeting the RMF peptide, derived from the intracellular tumor antigen Wilms’ tumor 1 (WT1) (Kroll et al., 2023). The gene discussed is WT1; the disease is neoplasm.